To read this content please select one of the options below:

Changing a drug from Rx to OTC status: the consumer behavior and public policy implications of switch drugs

Elizabeth H. Creyer (Associate Professor of Marketing and Transportation, University of Arkansas, Fayetteville, Arkansas, USA)
Illias Hrsistodoulakis (Greek Army, Athens, Greece)
Catherine A. Cole (Associate Professor of Marketing, University of Iowa, Iowa City, Iowa, USA)

Journal of Product & Brand Management

ISSN: 1061-0421

Article publication date: 1 February 2001

1916

Abstract

The rapid proliferation of drugs being switched from prescription (Rx) to over‐the‐counter (OTC) status within the USA has raised a number of important consumer behavior and public policy concerns. The following issue served as the focus of our research. Given the increasing assortment and widespread availability of Rx to OTC switch drugs, how might consumers’ health care preferences change? That is, what factors influence whether a consumer is more likely to visit their physician rather than self‐medicate symptoms of heartburn and indigestion with a new switch drug?

Keywords

Citation

Creyer, E.H., Hrsistodoulakis, I. and Cole, C.A. (2001), "Changing a drug from Rx to OTC status: the consumer behavior and public policy implications of switch drugs", Journal of Product & Brand Management, Vol. 10 No. 1, pp. 52-64. https://doi.org/10.1108/10610420110382821

Publisher

:

MCB UP Ltd

Copyright © 2001, MCB UP Limited

Related articles